Jun 3, 2026 06:52AM
Jun 3, 2026 06:19AM
Jun 2, 2026 09:21AM
May 29, 2026 10:42AM
May 18, 2026 01:08PM
May 14, 2026 02:40PM
Apr 28, 2026 06:43AM H.C. Wainwright Reiterates Buy Rating on Zymeworks (ZYME)
Apr 27, 2026 10:20AM
Apr 23, 2026 06:59AM
Apr 20, 2026 10:14AM
Apr 20, 2026 06:19AM
Apr 13, 2026 04:09PM
Apr 10, 2026 06:45AM
Apr 8, 2026 09:59AM Leerink Partners Downgrades Terns Pharmaceuticals (TERN) to Market Perform
Mar 30, 2026 06:19AM
Mar 27, 2026 04:33PM
Mar 20, 2026 03:03PM
Mar 20, 2026 06:09AM
Mar 10, 2026 08:43AM
Jan 30, 2026 06:28AM
Jan 23, 2026 06:20AM Leerink Partners Upgrades Relmada Therapeutics Inc (RLMD) to Outperform
Jan 8, 2026 10:21AM
Jan 7, 2026 07:20AM
Dec 17, 2025 04:03AM
Dec 17, 2025 04:02AM
Dec 9, 2025 10:56AM
Dec 8, 2025 02:11PM
Nov 20, 2025 06:19AM Leerink Partners Upgrades Agios Pharma (AGIO) to Outperform
Nov 19, 2025 02:40PM
Nov 18, 2025 06:50AM
Nov 17, 2025 02:07PM
Nov 11, 2025 04:50AM
Nov 10, 2025 01:18PM
Nov 10, 2025 04:36AM
Oct 31, 2025 06:08AM Leerink Partners Starts Immuneering Corporation (IMRX) at Outperform
Oct 27, 2025 06:51AM
Oct 14, 2025 06:08AM
Oct 6, 2025 02:44AM
Sep 17, 2025 06:10AM
Sep 9, 2025 07:00AM
Aug 11, 2025 04:27PM
Aug 4, 2025 10:20AM Leerink: 'We continue to recommend REGN shares'
Jul 7, 2025 10:23AM
Jul 3, 2025 06:47AM
Jun 27, 2025 08:51AM
Jun 24, 2025 10:24AM
Jun 2, 2025 06:49AM
Jun 2, 2025 01:10AM
Apr 17, 2025 09:19AM Leerink Partners Reiterates Outperform Rating on Eli Lilly (LLY)
Apr 2, 2025 06:49AM

166 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All